Phase II Study to determine the efficacy and safety of PIKA rabies vaccine containing the PIKA adjuvant with an accelerated regimen
Phase of Trial: Phase II
Latest Information Update: 11 Nov 2016
At a glance
- Drugs Rabies vaccine Yisheng Biopharma (Primary)
- Indications Rabies
- Focus Adverse reactions; Therapeutic Use
- Sponsors Yisheng Biopharma
- 03 Nov 2016 Status changed from recruiting to completed.
- 14 Jul 2016 According to a Yigheng Biopharma media release, this trial is expected to be completed by the third quarter of 2016.
- 18 Dec 2015 New trial record